HOXA5 and cervical carcinoma: All these data indicate that HOXA5 suppressed the expression of cyclinD1 by inhibiting the activity of the Wnt/β-catenin signaling pathway through inhibition of the nuclear translocation of the β-catenin protein in cervical cancer.